SBRT Radiotherapy for Non-operated Non-small-cell Lung Cancer (NSCLC), T1-T2, N0, M0

Unknown Not Applicable NCT00870116

Study Description

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible patients will be recruited and registered consecutively (no randomization). The estimated inclusion period is approximately 24 months. The duration of the research is 4 years. The number of patients required in this multicentric prospective study is 120: * 20 patients in the SBRT-1 arm (cyberknife), * 80 patients in the SBRT-2 arm (linear accelerator-based) * 20 patients in the conformational radiotherapy arm. This is a prospective, multicentric, non comparative and non randomized study.

Study Details

Registry ID:
NCT00870116
Conditions:
Non Small Cell Lung Cancer
Phase:
Not Applicable
Target Enrollment:
120 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (9 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →